Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study.

R Owens, D; Swallow, R; A Dugi, K; J Woerle, H

doi:10.1111/j.1464-5491.2011.03387.x

Public

Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study.

Shared by NobleBlocks on Nov 1, 2011 • 12:00 AM UTC

Authors:

D R Owens

R Swallow

K A Dugi

Abstract

AIMS: To examine the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in persons with Type 2 diabetes mellitus inadequately controlled [HbA(1c) 53-86 mmol/mol (7.0-10.0%)] by metformin and sulphonylurea combination treatment. METHODS: A multi-centre, 24-week, randomized, doubl...

Discussions